Clinical Trial Update: Effects of Imatinib in Subjects With Seasonal Allergic Rhinitis and Who Are Sensitive to Timothy Grass Pollen [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trials evaluated the safety and potential efficacy of imatinib in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Novartis | Conditions: Seasonal Allergic Rhinitis | Phase 1, Phase 2 | Status: COMPLETED